Comparing causal parameters with many treatments and positivity violations.

IF 2.8 2区 数学 Q2 BIOLOGY
Biometrika Pub Date : 2026-03-13 eCollection Date: 2026-01-01 DOI:10.1093/biomet/asag017
A McClean, Y Li, S Bae, M McAdams DeMarco, I Díaz, W Wu
{"title":"Comparing causal parameters with many treatments and positivity violations.","authors":"A McClean, Y Li, S Bae, M McAdams DeMarco, I Díaz, W Wu","doi":"10.1093/biomet/asag017","DOIUrl":null,"url":null,"abstract":"<p><p>Comparing outcomes across treatments is essential in medicine and public policy. To do so, researchers typically estimate a set of parameters, possibly counterfactual, each targeting adifferent treatment. Treatment-specific means are commonly used, but their identification requires a positivity assumption: every subject has a nonzero probability of receiving each treatment. This assumption is often implausible, especially when treatment can take many values. Causal parameters based on dynamic stochastic interventions offer robustness to positivity violations. However, comparing these parameters may fail to reflect the effects of the underlying target treatments because the parameters can depend on outcomes under nontarget treatments. To clarify when two parameters targeting different treatments yield a useful comparison of treatment efficacy, we propose a comparability criterion: if the conditional treatment-specific mean for one treatment is greater than that for another, then the corresponding causal parameter should also be greater. Many standard parameters fail to satisfy this criterion, but we show that only a mild positivity assumption is needed to identify parameters that yield useful comparisons. We then provide two simple examples that satisfy this criterion and are identifiable under the milder positivity assumption: trimmed and smooth-trimmed treatment-specific means with multivalued treatments. For smooth-trimmed treatment-specific means, we develop doubly robust-style estimators that attain parametric convergence rates under nonparametric conditions. We illustrate our methods with an analysis of dialysis providers in New York State.</p>","PeriodicalId":9001,"journal":{"name":"Biometrika","volume":"113 2","pages":"asag017"},"PeriodicalIF":2.8000,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13229585/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biometrika","FirstCategoryId":"100","ListUrlMain":"https://doi.org/10.1093/biomet/asag017","RegionNum":2,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Comparing outcomes across treatments is essential in medicine and public policy. To do so, researchers typically estimate a set of parameters, possibly counterfactual, each targeting adifferent treatment. Treatment-specific means are commonly used, but their identification requires a positivity assumption: every subject has a nonzero probability of receiving each treatment. This assumption is often implausible, especially when treatment can take many values. Causal parameters based on dynamic stochastic interventions offer robustness to positivity violations. However, comparing these parameters may fail to reflect the effects of the underlying target treatments because the parameters can depend on outcomes under nontarget treatments. To clarify when two parameters targeting different treatments yield a useful comparison of treatment efficacy, we propose a comparability criterion: if the conditional treatment-specific mean for one treatment is greater than that for another, then the corresponding causal parameter should also be greater. Many standard parameters fail to satisfy this criterion, but we show that only a mild positivity assumption is needed to identify parameters that yield useful comparisons. We then provide two simple examples that satisfy this criterion and are identifiable under the milder positivity assumption: trimmed and smooth-trimmed treatment-specific means with multivalued treatments. For smooth-trimmed treatment-specific means, we develop doubly robust-style estimators that attain parametric convergence rates under nonparametric conditions. We illustrate our methods with an analysis of dialysis providers in New York State.

比较因果参数与许多治疗和阳性违反。
在医学和公共政策中,比较不同治疗方法的结果至关重要。为了做到这一点,研究人员通常会估计一组参数,可能是反事实的,每个参数针对不同的治疗方法。治疗特定的手段通常被使用,但它们的识别需要一个积极的假设:每个受试者接受每种治疗的概率非零。这种假设通常是不可信的,特别是当治疗可以有很多值的时候。基于动态随机干预的因果参数对正性违规具有鲁棒性。然而,比较这些参数可能无法反映潜在靶向治疗的效果,因为这些参数可能取决于非靶向治疗下的结果。为了澄清针对不同治疗的两个参数何时能产生有用的治疗效果比较,我们提出了一个可比性标准:如果一种治疗的条件治疗特异性平均值大于另一种治疗的条件治疗特异性平均值,那么相应的因果参数也应该更大。许多标准参数不能满足这一标准,但我们表明,只需要一个温和的积极性假设来识别产生有用比较的参数。然后,我们提供了两个简单的例子,满足这一标准,并在较温和的积极性假设下可识别:具有多值处理的修剪和平滑修剪的治疗特定手段。对于平滑裁剪的特定处理手段,我们开发了双鲁棒式估计器,该估计器在非参数条件下获得参数收敛率。我们通过分析纽约州的透析提供者来说明我们的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biometrika
Biometrika 生物-生物学
CiteScore
5.50
自引率
3.70%
发文量
56
审稿时长
6-12 weeks
期刊介绍: Biometrika is primarily a journal of statistics in which emphasis is placed on papers containing original theoretical contributions of direct or potential value in applications. From time to time, papers in bordering fields are also published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书